P0715 Experience with Ustekinumab and Vedolizumab in Inflammatory Bowel Disease Patients: Single-Center Data
Halit Kandemir(Gazi University), Tarkan Karakan(Universitat Autònoma de Barcelona), Ali Karataş(Gazi University), Murat Kekilli(Gazi University), Mehmet Cindoruk(Gazi University), Kenan Moral(Unknown), Gülden Bilican(Gazi University)
Cited by 1
Related Papers
World Gastroenterology Organisation Global Guidelines
|Journal of Clinical Gastroenterology|2012|418
Mean platelet volume as an indicator of disease severity in patients with acute pancreatitis
|Clinics and Research in Hepatology and Gastroenterology|2011|117
Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: A retrospective analysis
|Digestive and Liver Disease|2009|91
Hemostatic Efficacy of Ankaferd Blood Stopper® in a Swine Bleeding Model
|Medical Principles and Practice|2009|86